Cameroon vs Congo: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Congo
100.0%
in 2024
Cameroon rank
1st
Congo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Congo
How they compare
Cameroon currently reports 100.0% against 100.0% in Congo, a difference of 0.0%.
The two have swapped places 5 times across 11 shared years of data; in 2013 it was Cameroon ahead.
Cameroon ranks 1st and Congo ranks 1st of 180 countries.
Across the 2 decades both report, Cameroon averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Cameroon | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 63.5% | 77.2% | 13.7% | Congo |
| 2020s | 97.2% | 69.8% | 27.4% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Congo?
- Cameroon, at 100.0% against 100.0% in Congo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Congo?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Congo?
- 11 years are reported by both, from 2013 to 2024.
- How do Cameroon and Congo rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Congo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.